Irene Karampela, Gerasimos Socrates Christodoulatos, Natalia Vallianou, Dimitrios Tsilingiris, Evangelia Chrysanthopoulou, George Skyllas, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Apostolos Armaganidis, Maria Dalamaga
Chemerin, a novel adipokine, is a potent chemoattractant molecule with antimicrobial properties, implicated in immune responses. Our aim was to investigate circulating Chemerin and its kinetics, early in sepsis in Critically Ill patients and its association with severity and prognosis. Serum Chemerin was determined in a cohort of 102 Critically Ill patients with sepsis during the first 48 h from sepsis onset and one week later, and in 102 age- and gender-matched healthy controls. patients were followed for 28 days and their outcomes were recorded. Circulating Chemerin was significantly higher in septic patients at onset compared to controls (342.3 ± 108.1 vs. 200.8 ± 40.1 μg/L, < 0.001). Chemerin decreased significantly from sepsis onset to one week later (342.3 ± 108.1 vs. 308.2 ± 108.5 μg/L, < 0.001), but remained higher than in controls. Chemerin was higher in patients presenting with septic shock than those with sepsis (sepsis onset: 403.2 ± 89.9 vs. 299.7 ± 99.5 μg/L, < 0.001; one week after: 374.9 ± 95.3 vs. 261.6 ± 91.9 μg/L, < 0.001), and in nonsurvivors than survivors (sepsis onset: 427.2 ± 96.7 vs. 306.9 ± 92.1 μg/L, < 0.001; one week after: 414.1 ± 94.5 vs. 264.2 ± 79.9 μg/L, < 0.001). Moreover, patients with septic shock and nonsurvivors, presented a significantly lower absolute and relative decrease in Chemerin one week after sepsis onset compared to baseline ( < 0.001). Based on ROC curve analyses, the diagnostic performance of Chemerin (AUC 0.78, 95% CI 0.69-0.87) was similar to C-reactive protein (CRP) (AUC 0.78, 95% CI 0.68-0.87) in discriminating sepsis severity. However, increased Chemerin at sepsis onset and one week later was an independent predictor of 28-day mortality (sepsis onset: HR 3.58, 95% CI 1.48-8.65, = 0.005; one week after: HR 10.01, 95% CI 4.32-23.20, < 0.001). Finally, serum Chemerin exhibited significant correlations with the severity scores, white blood cells, lactate, CRP and procalcitonin, as well as with biomarkers of glucose homeostasis, but not with cytokines and soluble urokinase-type plasminogen activator receptor (suPAR). Circulating Chemerin is increased early in sepsis and its kinetics may have diagnostic and prognostic value in Critically Ill patients. Further studies are needed to shed light on the role of Chemerin in sepsis.
